Dr. Adam S. Gracon

Raymond Rubin, M.D., has returned to Piedmont to become the Chief Scientific Officer and as a general and transplant hepatologist at Piedmont Transplant Institute. During his time at Piedmont from 1996-2011, he co-founded and served as the medical director of Piedmont's new liver transplant program (2004). From 2011 until 2014, Dr. Rubin left Atlanta for Boston to become a Medical Director at Vertex Pharmaceuticals, where he conducted research and evaluated new treatments for hepatitis C, other liver diseases, and inflammatory bowel disease. Dr. Rubin earned his medical degree from Cornell Medical College in New York, N.Y. He completed his residency in internal medicine and his fellowship in gastroenterology and hepatology at the Hospital of the University of Pennsylvania. Dr. Rubin graduated summa cum laude with bachelors in molecular and cellular biology and British literature. Dr. Rubin has been practicing medicine for 28 years. He is board certified in gastroenterology, internal medicine and transplant hepatology, and is a fellow of the American Association for the Study of Liver Diseases and of the American Gastroenterological Association.Dr. Rubin welcomes new patients and accepts most insurance plans. Dr. Rubin is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Hepatitis, Liver Failure, Visceromegaly, Enlarged Liver, and Liver Transplant.

Dr. Lance Stein is transplant hepatologist and the Medical Director of Piedmont's Hepatology and Liver Transplant Program since 2021. He has been at Piedmont since 2010. He is a Clinical Assistant Professor of Medicine at Mercer University School of Medicine. His special interests include viral hepatitis, alcohol related liver disease, acute on chronic liver failure, metabolic associated steatotic liver disease (MASH/MAFLD), and autoimmune liver diseases (including but not limited to autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis). He also is an expert in management of the complications of liver cirrhosis including portal hypertension and liver cancers.He is a fellow for the American Association for the Study of Liver Diseases, American Gastroenterology Association, and the American College of Physicians. He has served on national committees for the American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterology Association and the American Society of Transplantation.Following graduation from Temple University School of Medicine, he completed residency in internal medicine at Emory University School of Medicine, followed by a gastroenterology fellowship at the University of California, San Diego. He also completed a fellowship in advanced/transplant hepatology at both Columbia and Cornell-New York Presbyterian Hospitals. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Liver Failure, Hepatitis, Cirrhosis, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

Samir Parekh is a Transplant Surgeon in Atlanta, Georgia. Dr. Parekh has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His top areas of expertise are Hepatitis, Enlarged Liver, Hepatitis C, Liver Transplant, and Endoscopy.